Helius Medical Technologies Reported Results for its Portable Neuromodulation Stimulator (PoNS) Therapy in Patients Suffering from Traumatic Brain Injury (TBI)
Shots:
- The study evaluates the occupational performance & durabale Return-to-Work (RTW) status in patients (n=9) with TBI receiving the PoNS Therapy for a duration of 6mos. while patients perform rehabilitation exercises
- The results showed that 56% of the patients RTW, 80% returned to their prior full-time jobs for at least 6mos., 67% showed improvement in their balance & gait, in 89% balance & gait did not affect RTW & of patients facing headaches as a prevention to RTW, 50% reported a reduction in headache intensity
- PoNS is an orally applied therapy that delivers neurostimulation (to the tongue) through a controlled mouthpiece & is used with physical rehabilitation exercises, to improve balance & gait
Ref: Globenewswire | Image: Helius Medical Technologies
Related News:- Abbott Reports Positive Data of its Blood Test Technology Detecting Traumatic Brain Injury in Patients with Negative CT Scan
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Shivani is a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
